Dermatology · East Windsor, NJ
NPI
1497876601
Since 2007
Specialty
Dermatology
Code 207N00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
59 One Mile Rd Ext
East Windsor, NJ, 08520
Phone (609) 443-4500
Groups this clinician bills Medicare through
Medicare paid, 2024
$180K
2,987 services
Medicare patients, 2024
907
Average age 74
Drug cost, 2024
$372K
1,146 prescriptions
Company payments, 2025
$900
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wendy A Myers was code 99213 (office e&m - established), 726 times for 580 patients. In total Wendy A Myers billed 2,987 services in 39 codes, and Medicare paid $180K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-01-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 726 | 580 | $72.63 | $53K |
| 17003 Destruction Skin Lesion | Office | 721 | 162 | $6.11 | $4,405 |
| 17110 Destruction Skin Lesion | Office | 320 | 274 | $95.96 | $31K |
| 17000 Destruction Skin Lesion | Office | 300 | 231 | $46.20 | $14K |
| 11102 Skin Biopsy | Office | 193 | 176 | $79.78 | $15K |
| 99203 Office E&M - New | Office | 186 | 186 | $92.49 | $17K |
| 99212 Office E&M - Established | Office | 114 | 103 | $42.42 | $4,836 |
| 99214 Office E&M - Established | Office | 82 | 73 | $100.49 | $8,240 |
| 11103 Skin Biopsy | Office | 39 | 33 | $46.97 | $1,832 |
| 17262 Destruction Skin Lesion | Office | 37 | 32 | $149.78 | $5,542 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 35 | 20 | $0.75 | $26.34 |
| 11900 Skin | Office | 30 | 19 | $49.00 | $1,470 |
| 17111 Destruction Skin Lesion | Office | 27 | 15 | $117.60 | $3,175 |
| 99202 Office E&M - New | Office | 18 | 18 | $58.65 | $1,056 |
| 99204 Office E&M - New | Office | 15 | 15 | $131.45 | $1,972 |
By year: 2022 $199K for 3,224 services; 2023 $229K for 3,596 services; 2024 $180K for 2,987 services.
Medicare prescription drug claims, 2024
In 2024, the drug Wendy A Myers prescribed most often to Medicare patients was Clobetasol Propionate, with 178 prescriptions and refills. In total Wendy A Myers wrote 1,146 Medicare prescriptions that cost $372K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 178 | 202 | 115 | $6,521 |
| Triamcinolone Acetonide Generic | 130 | 155 | 96 | $1,465 |
| Ketoconazole Generic | 128 | 137 | 86 | $2,481 |
| Doxycycline Hyclate Generic | 60 | 66 | 38 | $1,807 |
| Mupirocin Generic | 56 | 57 | 43 | $294 |
| Desonide Generic | 47 | 55 | 37 | $1,573 |
| Fluorouracil Generic | 47 | 48 | 43 | $2,874 |
| Metronidazole Generic | 35 | 55 | 22 | $3,564 |
| Tretinoin Generic | 34 | 59 | 21 | $2,097 |
| Ivermectin Generic | 30 | 50 | 18 | $10K |
| Otezla Apremilast | 29 | 31 | Under 11 | $133K |
| Clindamycin Phosphate Generic | 28 | 30 | 15 | $698 |
| Minoxidil Generic | 23 | 49 | Under 11 | $219 |
| Valacyclovir Valacyclovir Hcl | 22 | 32 | 14 | $678 |
| Ammonium Lactate Generic | 21 | 25 | Under 11 | $185 |
Brand drugs: 155 claims; generic drugs: 991 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wendy A Myers $900 ($900 in general payments such as food, travel and fees) from 12 companies. The largest payer was Incyte Corporation with $325.
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation INCY | 8 | $325 |
| LEO Pharma Inc. | 10 | $293 |
| Abbvie Inc. ABBV | 4 | $65.69 |
| Janssen Biotech, Inc. JNJ | 3 | $50.32 |
| Botanix SB Inc | 2 | $37.13 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $34.45 |
| UCB, Inc. UCB.BR | 1 | $22.34 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $19.28 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $18.16 |
| Mayne Pharma Commercial LLC | 2 | $15.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.